Phosphodiesterase Type 5 Inhibitors for the Treatment of Male Lower Urinary Tract Symptoms

Ítems similars

• Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
  per: Elterman, Dean S, et al.
  Publicat: (2012)
• Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Erectile Dysfunction, and Phosphodiesterase-5 Inhibitors
  per: Roehrborn, Claus G
  Publicat: (2004)
• The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
  per: Umul, Mehmet, et al.
  Publicat: (2013)
• The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men
  per: Ng, Kok Kit, et al.
  Publicat: (2017)
• Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
  per: Pattanaik, Smita, et al.
  Publicat: (2018)